EVEROLIMUS Zentiva cpr 5 mg 30 pce
7680680000021
CH-68000
L01EG02
07.16.4.
Reimbursement limitations:
EVEROLIMUSZE
Traitement des patients atteints d'un carcinome à cellules rénales avancé après échec d'un traitement par …
1 / 3
google
Details
- Product number
- 6800002
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- everolimusum 5 mg, E 321, hypromellosum, lactosum 136 mg, lactosum monohydricum 12.5 mg, crospovidonum, magnesii stearas, pro compresso.
Articles (1)
Everolimus Zentiva 5 mg, Tabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | ANTOX |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
136.0 MG | Substance | HBESI |
|
(N/A)
|
12.5 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 929.50
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/08/2024
Authorization holder
Helvepharm AG
8500 Frauenfeld
Authorization information
- Swissmedic authorization number
- 68000
- Drug name
- Everolimus Zentiva, Tabletten
- Galenic form
- TAB
- ATC Code
- L01EG02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 20/05/2021
- Authorization expiration date
- 19/05/2026
- IT number
- 07.16.4.
- Domain
- Human medicine
Packaging details
- Description (FR)
- EVEROLIMUS Zentiva cpr 5 mg 30 pce
- Description (DE)
- EVEROLIMUS Zentiva Tabl 5 mg 30 Stk
- Market launch
- 20/05/2021
- Narcotic (BTM)
- No